SquatMachine的个人主页 - 老虎社区

SquatMachine

暂无个人介绍

IP属地：未知

3关注

5粉丝

0主题

0勋章

2021-12-06

price not being reflected

Why Moderna Is the Biggest Winner From COVID Boosters So Far<blockquote>为什么 Moderna 是迄今为止新冠疫苗的最大赢家</blockquote>

2021-12-03

Finally?!!

Didi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote>

2021-12-02

It's dropping like no tmw... hold?

Moderna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote>

2021-11-30

Didn't he say earlier it's good to go for 2022???

Moderna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote>

2021-08-25

lets get some volume in.

Some meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote>

2021-07-27

Buy the dip on NIO?

中概股跌幅持续扩大，小鹏汽车跌超15%

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3577793809591330","uuid":"3577793809591330","gmtCreate":1614954610056,"gmtModify":1706620613837,"name":"SquatMachine","pinyin":"squatmachine","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":3,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.66%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":606010283,"gmtCreate":1638800689347,"gmtModify":1638800895996,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"price not being reflected","listText":"price not being reflected","text":"price not being reflected","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606010283","repostId":"1125593879","repostType":2,"repost":{"id":"1125593879","kind":"news","pubTimestamp":1638756575,"share":"https://www.laohunote.com/m/news/1125593879?lang=zh_CN&edition=full","pubTime":"2021-12-06 10:09","market":"us","language":"en","title":"Why Moderna Is the Biggest Winner From COVID Boosters So Far<blockquote>为什么 Moderna 是迄今为止新冠疫苗的最大赢家</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1125593879","media":"Motley Fool","summary":"It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authoriz","content":"<p>It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authorized boosters for the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) for certain groups. Around two and half months ago, the agency granted authorizations for boosters for Moderna's (NASDAQ:MRNA) and Johnson &amp; Johnson's (NYSE:JNJ) vaccines, with limitations for which individuals could receive the Moderna booster.</p><p><blockquote>距离美国已经过去了大约三个半月。美国食品药品监督管理局 (FDA) 批准辉瑞 (NYSE:PFE) 和 BioNTech (NASDAQ:BNTX) 为某些群体开发的 COVID-19 疫苗加强剂。大约两个半月前，该机构批准了 Moderna（纳斯达克股票代码：MRNA）和强生公司（纽约证券交易所股票代码：JNJ）疫苗的加强剂，但对个人可以接受 Moderna 加强剂的数量有限制。</blockquote></p><p> A little over two weeks ago, the FDA broadened its Emergency Use Authorization for the Pfizer-BioNTech and Moderna boosters to include all adults ages 18 and older. Overall, close to 42 million Americans have received booster shots.</p><p><blockquote>两个多星期前，FDA扩大了辉瑞-BioNTech和Moderna加强剂的紧急使用授权，将所有18岁及以上的成年人包括在内。总体而言，近 4200 万美国人接受了加强注射。</blockquote></p><p> Which vaccine maker is winning the battle of the boosters so far? It's still early, but Moderna appears to be ahead in several respects</p><p><blockquote>到目前为止，哪家疫苗制造商正在赢得加强剂之战？现在还为时尚早，但 Moderna 似乎在几个方面处于领先地位</blockquote></p><p> <b>Analyzing the data</b></p><p><blockquote><b>分析数据</b></blockquote></p><p> More booster doses of the Pfizer-BioNTech vaccine have been given than have been administered for the Moderna and J&amp;J boosters. Pfizer and BioNTech are clearly in the lead on this front.</p><p><blockquote>辉瑞-BioNTech疫苗的加强剂量超过了Moderna和J&amp;J加强剂。辉瑞和BioNTech显然在这方面处于领先地位。</blockquote></p><p> You'd expect that more people would have received the Pfizer-BioNTech booster. It's been available for many Americans (including those ages 65 and older) for a month longer than the other two vaccine types.</p><p><blockquote>你会期望更多的人会接受辉瑞-BioNTech加强剂。许多美国人（包括65岁及以上的人）的接种时间比其他两种疫苗多一个月。</blockquote></p><p> Also, many more individuals received the Pfizer-BioNTech vaccine initially than received the other two vaccines. A lot of those people chose to receive the booster of the same vaccine that they received for their primary series. The chart below shows how the different vaccines stack up against each other based on the fully vaccinated numbers.</p><p><blockquote>此外，最初接受辉瑞-BioNTech疫苗的人比接受其他两种疫苗的人多得多。这些人中的许多人选择接受与他们在主要系列中接受的相同疫苗的加强。下图显示了基于完全接种疫苗的数量，不同疫苗是如何相互对抗的。</blockquote></p><p> So why do I maintain that Moderna is the biggest winner with boosters so far and not Pfizer or BioNTech? There are three reasons.</p><p><blockquote>那么，为什么我坚持认为Moderna是迄今为止最大的助推器赢家，而不是辉瑞或BioNTech呢？原因有三个。</blockquote></p><p> First, from a financial standpoint, Moderna's 18 million booster doses made it more money than Pfizer or BioNTech made from their 23.3 million or so booster doses. Moderna doesn't have to split its profits as Pfizer and BioNTech do.</p><p><blockquote>首先，从财务角度来看，Moderna 的 1800 万剂加强剂比辉瑞或 BioNTech 的 2330 万剂左右加强剂赚的钱还要多。Moderna 不必像辉瑞和 BioNTech 那样分配利润。</blockquote></p><p> Second, Moderna is gaining more traction with boosters than Pfizer-BioNTech or J&amp;J are. A little over 25% of the number of fully vaccinated individuals receiving the primary series of the Moderna vaccine have received Moderna boosters. The ratio is 21.3% for Pfizer-BioNTech.</p><p><blockquote>其次，与辉瑞-BioNTech或强生相比，Moderna在加强剂方面获得了更多的牵引力。接受Moderna疫苗初级系列的完全接种疫苗的个体中，略高于25%的人接受了Moderna加强剂。辉瑞-BioNTech的这一比例为21.3%。</blockquote></p><p> Third, with the FDA allowing mix-and-match boosters, more people appear to be switching from another vaccine to Moderna than they are to any other vaccine type. For those who initially received the J&amp;J vaccine, 42.5% so far have gone with the Moderna booster versus 31.2% for a Pfizer-BioNTech booster and only 26.2% for a J&amp;J booster.</p><p><blockquote>第三，随着FDA允许混合搭配加强剂，从另一种疫苗转向Moderna的人似乎比任何其他疫苗类型的人都多。对于那些最初接受J&amp;J疫苗的人来说，到目前为止，42.5%的人使用了Moderna加强剂，而31.2%的人使用了辉瑞-BioNTech加强剂，只有26.2%的人使用了J&amp;J加强剂。</blockquote></p><p> <b>Why is Moderna winning?</b></p><p><blockquote><b>为什么Moderna会赢？</b></blockquote></p><p> We don't know for sure why Moderna seems to be gaining momentum. However, I have a theory for why it could be happening.</p><p><blockquote>我们不确定为什么 Moderna 似乎势头强劲。然而，我有一个理论来解释为什么会发生这种情况。</blockquote></p><p> My hunch is that many Americans have heard that Moderna's efficacy against the delta variant is higher than the efficacy of the Pfizer-BioNTech and Johnson &amp; Johnson vaccines. The initial efficacy of the single-shot J&amp;J vaccine was well below its two messenger RNA vaccine rivals. And the efficacy of the Pfizer-BioNTech vaccine appears to have waned more than the Moderna vaccine has with the rise of the delta variant.</p><p><blockquote>我的预感是，许多美国人都听说过 Moderna 对德尔塔变异毒株的效力高于辉瑞-BioNTech 和强生疫苗的效力。强生单针疫苗的初始效力远低于其两种信使RNA疫苗竞争对手。随着德尔塔变异毒株的上升，辉瑞-BioNTech疫苗的效力似乎比Moderna疫苗减弱得多。</blockquote></p><p> I suspect that preliminary data showing that a mix-and-match combination of the Pfizer-BioNTech primary series and a Moderna booster provides a higher efficacy could also be making a difference to some extent. Singapore's minister of health even recently recommended that citizens in the country who initially received the Pfizer-BioNTech vaccine get the Moderna booster.</p><p><blockquote>我怀疑，初步数据显示辉瑞-BioNTech初级系列和Moderna加强剂的混合搭配组合提供了更高的功效，这也可能在某种程度上产生影响。新加坡卫生部长最近甚至建议该国最初接种辉瑞-BioNTech疫苗的公民接种Moderna加强剂。</blockquote></p><p> <b>What really matters</b></p><p><blockquote><b>真正重要的是什么</b></blockquote></p><p> Don't expect Moderna's relative outperformance in boosters to do much for the vaccine stock. Many investors aren't paying attention to the data. And the U.S. has already purchased enough doses from Moderna to meet the demand, including boosters.</p><p><blockquote>不要指望 Moderna 在加强剂方面的相对优异表现会对疫苗库存产生太大影响。许多投资者并没有关注这些数据。美国已经从 Moderna 购买了足够的剂量来满足需求，包括加强剂。</blockquote></p><p> What really matters for Moderna is how strong the longer-term demand will be for its COVID-19 vaccine. The company's efforts fighting the new omicron variant could play a key role in shaping that demand. But the most important factors will be whether or not annual vaccines are required to prevent COVID-19 and, if so, what price Moderna will be able to charge.</p><p><blockquote>对 Moderna 来说真正重要的是对其 COVID-19 疫苗的长期需求有多强劲。该公司对抗新奥密克戎变种的努力可能会在塑造这一需求方面发挥关键作用。但最重要的因素将是是否需要每年接种疫苗来预防 COVID-19，如果是，Moderna 将能够收取什么价格。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Is the Biggest Winner From COVID Boosters So Far<blockquote>为什么 Moderna 是迄今为止新冠疫苗的最大赢家</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Is the Biggest Winner From COVID Boosters So Far<blockquote>为什么 Moderna 是迄今为止新冠疫苗的最大赢家</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-06 10:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authorized boosters for the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) for certain groups. Around two and half months ago, the agency granted authorizations for boosters for Moderna's (NASDAQ:MRNA) and Johnson &amp; Johnson's (NYSE:JNJ) vaccines, with limitations for which individuals could receive the Moderna booster.</p><p><blockquote>距离美国已经过去了大约三个半月。美国食品药品监督管理局 (FDA) 批准辉瑞 (NYSE:PFE) 和 BioNTech (NASDAQ:BNTX) 为某些群体开发的 COVID-19 疫苗加强剂。大约两个半月前，该机构批准了 Moderna（纳斯达克股票代码：MRNA）和强生公司（纽约证券交易所股票代码：JNJ）疫苗的加强剂，但对个人可以接受 Moderna 加强剂的数量有限制。</blockquote></p><p> A little over two weeks ago, the FDA broadened its Emergency Use Authorization for the Pfizer-BioNTech and Moderna boosters to include all adults ages 18 and older. Overall, close to 42 million Americans have received booster shots.</p><p><blockquote>两个多星期前，FDA扩大了辉瑞-BioNTech和Moderna加强剂的紧急使用授权，将所有18岁及以上的成年人包括在内。总体而言，近 4200 万美国人接受了加强注射。</blockquote></p><p> Which vaccine maker is winning the battle of the boosters so far? It's still early, but Moderna appears to be ahead in several respects</p><p><blockquote>到目前为止，哪家疫苗制造商正在赢得加强剂之战？现在还为时尚早，但 Moderna 似乎在几个方面处于领先地位</blockquote></p><p> <b>Analyzing the data</b></p><p><blockquote><b>分析数据</b></blockquote></p><p> More booster doses of the Pfizer-BioNTech vaccine have been given than have been administered for the Moderna and J&amp;J boosters. Pfizer and BioNTech are clearly in the lead on this front.</p><p><blockquote>辉瑞-BioNTech疫苗的加强剂量超过了Moderna和J&amp;J加强剂。辉瑞和BioNTech显然在这方面处于领先地位。</blockquote></p><p> You'd expect that more people would have received the Pfizer-BioNTech booster. It's been available for many Americans (including those ages 65 and older) for a month longer than the other two vaccine types.</p><p><blockquote>你会期望更多的人会接受辉瑞-BioNTech加强剂。许多美国人（包括65岁及以上的人）的接种时间比其他两种疫苗多一个月。</blockquote></p><p> Also, many more individuals received the Pfizer-BioNTech vaccine initially than received the other two vaccines. A lot of those people chose to receive the booster of the same vaccine that they received for their primary series. The chart below shows how the different vaccines stack up against each other based on the fully vaccinated numbers.</p><p><blockquote>此外，最初接受辉瑞-BioNTech疫苗的人比接受其他两种疫苗的人多得多。这些人中的许多人选择接受与他们在主要系列中接受的相同疫苗的加强。下图显示了基于完全接种疫苗的数量，不同疫苗是如何相互对抗的。</blockquote></p><p> So why do I maintain that Moderna is the biggest winner with boosters so far and not Pfizer or BioNTech? There are three reasons.</p><p><blockquote>那么，为什么我坚持认为Moderna是迄今为止最大的助推器赢家，而不是辉瑞或BioNTech呢？原因有三个。</blockquote></p><p> First, from a financial standpoint, Moderna's 18 million booster doses made it more money than Pfizer or BioNTech made from their 23.3 million or so booster doses. Moderna doesn't have to split its profits as Pfizer and BioNTech do.</p><p><blockquote>首先，从财务角度来看，Moderna 的 1800 万剂加强剂比辉瑞或 BioNTech 的 2330 万剂左右加强剂赚的钱还要多。Moderna 不必像辉瑞和 BioNTech 那样分配利润。</blockquote></p><p> Second, Moderna is gaining more traction with boosters than Pfizer-BioNTech or J&amp;J are. A little over 25% of the number of fully vaccinated individuals receiving the primary series of the Moderna vaccine have received Moderna boosters. The ratio is 21.3% for Pfizer-BioNTech.</p><p><blockquote>其次，与辉瑞-BioNTech或强生相比，Moderna在加强剂方面获得了更多的牵引力。接受Moderna疫苗初级系列的完全接种疫苗的个体中，略高于25%的人接受了Moderna加强剂。辉瑞-BioNTech的这一比例为21.3%。</blockquote></p><p> Third, with the FDA allowing mix-and-match boosters, more people appear to be switching from another vaccine to Moderna than they are to any other vaccine type. For those who initially received the J&amp;J vaccine, 42.5% so far have gone with the Moderna booster versus 31.2% for a Pfizer-BioNTech booster and only 26.2% for a J&amp;J booster.</p><p><blockquote>第三，随着FDA允许混合搭配加强剂，从另一种疫苗转向Moderna的人似乎比任何其他疫苗类型的人都多。对于那些最初接受J&amp;J疫苗的人来说，到目前为止，42.5%的人使用了Moderna加强剂，而31.2%的人使用了辉瑞-BioNTech加强剂，只有26.2%的人使用了J&amp;J加强剂。</blockquote></p><p> <b>Why is Moderna winning?</b></p><p><blockquote><b>为什么Moderna会赢？</b></blockquote></p><p> We don't know for sure why Moderna seems to be gaining momentum. However, I have a theory for why it could be happening.</p><p><blockquote>我们不确定为什么 Moderna 似乎势头强劲。然而，我有一个理论来解释为什么会发生这种情况。</blockquote></p><p> My hunch is that many Americans have heard that Moderna's efficacy against the delta variant is higher than the efficacy of the Pfizer-BioNTech and Johnson &amp; Johnson vaccines. The initial efficacy of the single-shot J&amp;J vaccine was well below its two messenger RNA vaccine rivals. And the efficacy of the Pfizer-BioNTech vaccine appears to have waned more than the Moderna vaccine has with the rise of the delta variant.</p><p><blockquote>我的预感是，许多美国人都听说过 Moderna 对德尔塔变异毒株的效力高于辉瑞-BioNTech 和强生疫苗的效力。强生单针疫苗的初始效力远低于其两种信使RNA疫苗竞争对手。随着德尔塔变异毒株的上升，辉瑞-BioNTech疫苗的效力似乎比Moderna疫苗减弱得多。</blockquote></p><p> I suspect that preliminary data showing that a mix-and-match combination of the Pfizer-BioNTech primary series and a Moderna booster provides a higher efficacy could also be making a difference to some extent. Singapore's minister of health even recently recommended that citizens in the country who initially received the Pfizer-BioNTech vaccine get the Moderna booster.</p><p><blockquote>我怀疑，初步数据显示辉瑞-BioNTech初级系列和Moderna加强剂的混合搭配组合提供了更高的功效，这也可能在某种程度上产生影响。新加坡卫生部长最近甚至建议该国最初接种辉瑞-BioNTech疫苗的公民接种Moderna加强剂。</blockquote></p><p> <b>What really matters</b></p><p><blockquote><b>真正重要的是什么</b></blockquote></p><p> Don't expect Moderna's relative outperformance in boosters to do much for the vaccine stock. Many investors aren't paying attention to the data. And the U.S. has already purchased enough doses from Moderna to meet the demand, including boosters.</p><p><blockquote>不要指望 Moderna 在加强剂方面的相对优异表现会对疫苗库存产生太大影响。许多投资者并没有关注这些数据。美国已经从 Moderna 购买了足够的剂量来满足需求，包括加强剂。</blockquote></p><p> What really matters for Moderna is how strong the longer-term demand will be for its COVID-19 vaccine. The company's efforts fighting the new omicron variant could play a key role in shaping that demand. But the most important factors will be whether or not annual vaccines are required to prevent COVID-19 and, if so, what price Moderna will be able to charge.</p><p><blockquote>对 Moderna 来说真正重要的是对其 COVID-19 疫苗的长期需求有多强劲。该公司对抗新奥密克戎变种的努力可能会在塑造这一需求方面发挥关键作用。但最重要的因素将是是否需要每年接种疫苗来预防 COVID-19，如果是，Moderna 将能够收取什么价格。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/05/why-moderna-is-the-biggest-winner-from-covid-boost/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/12/05/why-moderna-is-the-biggest-winner-from-covid-boost/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125593879","content_text":"It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authorized boosters for the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) for certain groups. Around two and half months ago, the agency granted authorizations for boosters for Moderna's (NASDAQ:MRNA) and Johnson & Johnson's (NYSE:JNJ) vaccines, with limitations for which individuals could receive the Moderna booster.\n\nA little over two weeks ago, the FDA broadened its Emergency Use Authorization for the Pfizer-BioNTech and Moderna boosters to include all adults ages 18 and older. Overall, close to 42 million Americans have received booster shots.\n\nWhich vaccine maker is winning the battle of the boosters so far? It's still early, but Moderna appears to be ahead in several respects\nAnalyzing the data\nMore booster doses of the Pfizer-BioNTech vaccine have been given than have been administered for the Moderna and J&J boosters. Pfizer and BioNTech are clearly in the lead on this front.\n\nYou'd expect that more people would have received the Pfizer-BioNTech booster. It's been available for many Americans (including those ages 65 and older) for a month longer than the other two vaccine types.\n\nAlso, many more individuals received the Pfizer-BioNTech vaccine initially than received the other two vaccines. A lot of those people chose to receive the booster of the same vaccine that they received for their primary series. The chart below shows how the different vaccines stack up against each other based on the fully vaccinated numbers.\n\nSo why do I maintain that Moderna is the biggest winner with boosters so far and not Pfizer or BioNTech? There are three reasons.\n\nFirst, from a financial standpoint, Moderna's 18 million booster doses made it more money than Pfizer or BioNTech made from their 23.3 million or so booster doses. Moderna doesn't have to split its profits as Pfizer and BioNTech do.\n\nSecond, Moderna is gaining more traction with boosters than Pfizer-BioNTech or J&J are. A little over 25% of the number of fully vaccinated individuals receiving the primary series of the Moderna vaccine have received Moderna boosters. The ratio is 21.3% for Pfizer-BioNTech.\n\nThird, with the FDA allowing mix-and-match boosters, more people appear to be switching from another vaccine to Moderna than they are to any other vaccine type. For those who initially received the J&J vaccine, 42.5% so far have gone with the Moderna booster versus 31.2% for a Pfizer-BioNTech booster and only 26.2% for a J&J booster.\n\nWhy is Moderna winning?\nWe don't know for sure why Moderna seems to be gaining momentum. However, I have a theory for why it could be happening.\n\nMy hunch is that many Americans have heard that Moderna's efficacy against the delta variant is higher than the efficacy of the Pfizer-BioNTech and Johnson & Johnson vaccines. The initial efficacy of the single-shot J&J vaccine was well below its two messenger RNA vaccine rivals. And the efficacy of the Pfizer-BioNTech vaccine appears to have waned more than the Moderna vaccine has with the rise of the delta variant.\n\nI suspect that preliminary data showing that a mix-and-match combination of the Pfizer-BioNTech primary series and a Moderna booster provides a higher efficacy could also be making a difference to some extent. Singapore's minister of health even recently recommended that citizens in the country who initially received the Pfizer-BioNTech vaccine get the Moderna booster.\n\nWhat really matters\nDon't expect Moderna's relative outperformance in boosters to do much for the vaccine stock. Many investors aren't paying attention to the data. And the U.S. has already purchased enough doses from Moderna to meet the demand, including boosters.\n\nWhat really matters for Moderna is how strong the longer-term demand will be for its COVID-19 vaccine. The company's efforts fighting the new omicron variant could play a key role in shaping that demand. But the most important factors will be whether or not annual vaccines are required to prevent COVID-19 and, if so, what price Moderna will be able to charge.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601845900,"gmtCreate":1638514700795,"gmtModify":1638514700890,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Finally?!!","listText":"Finally?!!","text":"Finally?!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601845900","repostId":"1149654291","repostType":2,"repost":{"id":"1149654291","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638514400,"share":"https://www.laohunote.com/m/news/1149654291?lang=zh_CN&edition=full","pubTime":"2021-12-03 14:53","market":"us","language":"en","title":"Didi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1149654291","media":"Tiger Newspress","summary":"It's reported that Didi reintroduces its apps in Apple Store.\nHowever, Didi said that it was a rumor","content":"<p>It's&nbsp;reported&nbsp;that&nbsp;Didi&nbsp;reintroduces its apps in Apple&nbsp;Store.</p><p><blockquote>据悉，滴滴将在苹果商店重新推出其应用程序。</blockquote></p><p> However,&nbsp;Didi&nbsp;said&nbsp;that&nbsp;it&nbsp;was&nbsp;a&nbsp;rumor.</p><p><blockquote>不过，滴滴方面表示，这是谣言。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Didi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDidi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 14:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>It's&nbsp;reported&nbsp;that&nbsp;Didi&nbsp;reintroduces its apps in Apple&nbsp;Store.</p><p><blockquote>据悉，滴滴将在苹果商店重新推出其应用程序。</blockquote></p><p> However,&nbsp;Didi&nbsp;said&nbsp;that&nbsp;it&nbsp;was&nbsp;a&nbsp;rumor.</p><p><blockquote>不过，滴滴方面表示，这是谣言。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149654291","content_text":"It's reported that Didi reintroduces its apps in Apple Store.\nHowever, Didi said that it was a rumor.","news_type":1,"symbols_score_info":{"DIDI":0.9}},"isVote":1,"tweetType":1,"viewCount":2742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603468710,"gmtCreate":1638440850258,"gmtModify":1638440971157,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"It's dropping like no tmw... hold?","listText":"It's dropping like no tmw... hold?","text":"It's dropping like no tmw... hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603468710","repostId":"1138497635","repostType":2,"repost":{"id":"1138497635","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638436217,"share":"https://www.laohunote.com/m/news/1138497635?lang=zh_CN&edition=full","pubTime":"2021-12-02 17:10","market":"us","language":"en","title":"Moderna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138497635","media":"Tiger Newspress","summary":"Moderna shares dipped more than 2% in premarket trading as it could be sued over vaccines as court u","content":"<p>Moderna shares dipped more than&nbsp;2% in premarket trading&nbsp;as&nbsp;it&nbsp;could be sued over vaccines as court upholds Arbutus patents.</p><p><blockquote>由于法院支持杨梅专利，Moderna 股价在盘前交易中下跌超过 2%，该公司可能因疫苗被起诉。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c4b23d228b24ede7e56c373ea5ecd787\" tg-width=\"853\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Moderna Inc&nbsp;could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.</p><p><blockquote>在联邦上诉法院周三驳回了 Moderna Inc 对 Arbutus Biopharma Corp. 专利的质疑后，Moderna Inc 可能面临其 COVID-19 疫苗的专利侵权诉讼。</blockquote></p><p> The Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.</p><p><blockquote>美国联邦巡回上诉法院维持了行政小组的调查结果，即杨梅的专利（可能涵盖疫苗中使用的技术）是有效的，因为所涉及的科学以前并不为人所知。</blockquote></p><p> Moderna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.</p><p><blockquote>Moderna 此前在法庭文件中表示，如果专利得到支持，它认为 Arbutus 可能会提起诉讼，要求其 COVID-19 疫苗支付版税。</blockquote></p><p> The company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.</p><p><blockquote>该公司上个月预测，其 COVID-19 疫苗 2021 年销售额将在 150 亿至 180 亿美元之间，2022 年销售额将在 170 亿至 220 亿美元之间。</blockquote></p><p> Jefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.</p><p><blockquote>Jefferies 分析师 Dennis Ding 表示，侵权诉讼是可能的，但可能会拖延数年，并补充说 Arbutus 可能会满足于少量版税。</blockquote></p><p> \"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.</p><p><blockquote>“当你考虑疫苗带来的收入机会时，就像每年 10 亿美元到 200 亿美元一样，少量的低个位数特许权使用费对 Moderna 来说并不重要，”他说。</blockquote></p><p> Both patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.</p><p><blockquote>这两项专利都涉及所谓的脂质纳米颗粒，这些纳米颗粒将遗传物质（称为信使 RNA (mRNA)）包裹在疫苗中。这项技术可能有助于开发未来针对其他疾病的基于mRNA的疫苗。</blockquote></p><p> Moderna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.</p><p><blockquote>Moderna 最初向联邦专利局下属的美国专利审判和上诉委员会对这些专利提出质疑。委员会同意Moderna的观点，即其中一项专利的某些部分无效，但在其他方面支持Arbutus，联邦巡回法院维持了其调查结果。</blockquote></p><p> The patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.</p><p><blockquote>这些专利授权给 Genevant Sciences Inc.，该公司由 Arbutus 和 Roivant Sciences Ltd. 于 2018 年创立。Roivant 拥有 Genevant 约 80% 的股份，Arbutus 拥有其余部分。</blockquote></p><p> Moderna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).</p><p><blockquote>Moderna 还卷入了与美国国立卫生研究院 (NIH) 长达数月的 COVID-19 疫苗专利冲突。</blockquote></p><p> NIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.</p><p><blockquote>NIH 声称，其三名科学家帮助设计了 Moderna 价值数十亿美元的疫苗中使用的基因序列，并应在专利申请中命名，但该公司不同意这一说法。</blockquote></p><p> The company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.</p><p><blockquote>该公司坚称，该公司疫苗中的mRNA序列是由Moderna的科学家独家选择的，没有NIH科学家的输入。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-02 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna shares dipped more than&nbsp;2% in premarket trading&nbsp;as&nbsp;it&nbsp;could be sued over vaccines as court upholds Arbutus patents.</p><p><blockquote>由于法院支持杨梅专利，Moderna 股价在盘前交易中下跌超过 2%，该公司可能因疫苗被起诉。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c4b23d228b24ede7e56c373ea5ecd787\" tg-width=\"853\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Moderna Inc&nbsp;could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.</p><p><blockquote>在联邦上诉法院周三驳回了 Moderna Inc 对 Arbutus Biopharma Corp. 专利的质疑后，Moderna Inc 可能面临其 COVID-19 疫苗的专利侵权诉讼。</blockquote></p><p> The Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.</p><p><blockquote>美国联邦巡回上诉法院维持了行政小组的调查结果，即杨梅的专利（可能涵盖疫苗中使用的技术）是有效的，因为所涉及的科学以前并不为人所知。</blockquote></p><p> Moderna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.</p><p><blockquote>Moderna 此前在法庭文件中表示，如果专利得到支持，它认为 Arbutus 可能会提起诉讼，要求其 COVID-19 疫苗支付版税。</blockquote></p><p> The company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.</p><p><blockquote>该公司上个月预测，其 COVID-19 疫苗 2021 年销售额将在 150 亿至 180 亿美元之间，2022 年销售额将在 170 亿至 220 亿美元之间。</blockquote></p><p> Jefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.</p><p><blockquote>Jefferies 分析师 Dennis Ding 表示，侵权诉讼是可能的，但可能会拖延数年，并补充说 Arbutus 可能会满足于少量版税。</blockquote></p><p> \"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.</p><p><blockquote>“当你考虑疫苗带来的收入机会时，就像每年 10 亿美元到 200 亿美元一样，少量的低个位数特许权使用费对 Moderna 来说并不重要，”他说。</blockquote></p><p> Both patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.</p><p><blockquote>这两项专利都涉及所谓的脂质纳米颗粒，这些纳米颗粒将遗传物质（称为信使 RNA (mRNA)）包裹在疫苗中。这项技术可能有助于开发未来针对其他疾病的基于mRNA的疫苗。</blockquote></p><p> Moderna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.</p><p><blockquote>Moderna 最初向联邦专利局下属的美国专利审判和上诉委员会对这些专利提出质疑。委员会同意Moderna的观点，即其中一项专利的某些部分无效，但在其他方面支持Arbutus，联邦巡回法院维持了其调查结果。</blockquote></p><p> The patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.</p><p><blockquote>这些专利授权给 Genevant Sciences Inc.，该公司由 Arbutus 和 Roivant Sciences Ltd. 于 2018 年创立。Roivant 拥有 Genevant 约 80% 的股份，Arbutus 拥有其余部分。</blockquote></p><p> Moderna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).</p><p><blockquote>Moderna 还卷入了与美国国立卫生研究院 (NIH) 长达数月的 COVID-19 疫苗专利冲突。</blockquote></p><p> NIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.</p><p><blockquote>NIH 声称，其三名科学家帮助设计了 Moderna 价值数十亿美元的疫苗中使用的基因序列，并应在专利申请中命名，但该公司不同意这一说法。</blockquote></p><p> The company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.</p><p><blockquote>该公司坚称，该公司疫苗中的mRNA序列是由Moderna的科学家独家选择的，没有NIH科学家的输入。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138497635","content_text":"Moderna shares dipped more than 2% in premarket trading as it could be sued over vaccines as court upholds Arbutus patents.\n\nModerna Inc could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.\nThe Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.\nModerna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.\nThe company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.\nJefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.\n\"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.\nBoth patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.\nModerna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.\nThe patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.\nModerna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).\nNIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.\nThe company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":4328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609888045,"gmtCreate":1638264393592,"gmtModify":1638264456117,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Didn't he say earlier it's good to go for 2022???","listText":"Didn't he say earlier it's good to go for 2022???","text":"Didn't he say earlier it's good to go for 2022???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609888045","repostId":"1176161322","repostType":2,"repost":{"id":"1176161322","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638263039,"share":"https://www.laohunote.com/m/news/1176161322?lang=zh_CN&edition=full","pubTime":"2021-11-30 17:03","market":"us","language":"en","title":"Moderna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176161322","media":"Tiger Newspress","summary":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective agai","content":"<p>Moderna stock slid 1.5% in premarket trading&nbsp;as&nbsp;Moderna CEO said vaccines likely less effective against Omicron.</p><p><blockquote>Moderna 首席执行官表示疫苗对奥密克戎的效果可能较差，Moderna 股价在盘前交易中下跌 1.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>制药商 Moderna 的负责人表示，新冠肺炎疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对疫情轨迹的新担忧。</blockquote></p><p> \"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 在接受英国《金融时报》采访时表示：“我认为，没有哪个世界（效率）能达到与达美航空相同的水平……”</blockquote></p><p> \"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p><p><blockquote>“我认为这将是一个物质下降。我只是不知道下降多少，因为我们需要等待数据。但我交谈过的所有科学家......都说‘这不会是好的’。”</blockquote></p><p> Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p><p><blockquote>疫苗耐药性可能会导致更多的疾病和住院，并延长疫情，他的言论引发了石油、股票和澳元等增长风险资产的抛售。</blockquote></p><p> Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p><p><blockquote>班塞尔补充说，病毒用来感染人类细胞的蛋白质刺突有大量突变，这意味着目前的疫苗作物可能需要修改。</blockquote></p><p> He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p><p><blockquote>他早些时候在 CNBC 上表示，可能需要几个月的时间才能开始运送一种确实有效对抗奥密克戎的疫苗。</blockquote></p><p> Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p><p><blockquote>尽管缺乏关于其严重性的信息，但对新变种的恐惧已经引发了一些经济重新开放计划的延迟，以及一些旅行和行动限制的重新实施。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-30 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna stock slid 1.5% in premarket trading&nbsp;as&nbsp;Moderna CEO said vaccines likely less effective against Omicron.</p><p><blockquote>Moderna 首席执行官表示疫苗对奥密克戎的效果可能较差，Moderna 股价在盘前交易中下跌 1.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>制药商 Moderna 的负责人表示，新冠肺炎疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对疫情轨迹的新担忧。</blockquote></p><p> \"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 在接受英国《金融时报》采访时表示：“我认为，没有哪个世界（效率）能达到与达美航空相同的水平……”</blockquote></p><p> \"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p><p><blockquote>“我认为这将是一个物质下降。我只是不知道下降多少，因为我们需要等待数据。但我交谈过的所有科学家......都说‘这不会是好的’。”</blockquote></p><p> Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p><p><blockquote>疫苗耐药性可能会导致更多的疾病和住院，并延长疫情，他的言论引发了石油、股票和澳元等增长风险资产的抛售。</blockquote></p><p> Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p><p><blockquote>班塞尔补充说，病毒用来感染人类细胞的蛋白质刺突有大量突变，这意味着目前的疫苗作物可能需要修改。</blockquote></p><p> He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p><p><blockquote>他早些时候在 CNBC 上表示，可能需要几个月的时间才能开始运送一种确实有效对抗奥密克戎的疫苗。</blockquote></p><p> Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p><p><blockquote>尽管缺乏关于其严重性的信息，但对新变种的恐惧已经引发了一些经济重新开放计划的延迟，以及一些旅行和行动限制的重新实施。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176161322","content_text":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective against Omicron.\n\nThe head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nVaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.\nBancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.\nHe had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.\nFear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3895,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837488653,"gmtCreate":1629905341372,"gmtModify":1633681558541,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"lets get some volume in.","listText":"lets get some volume in.","text":"lets get some volume in.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837488653","repostId":"1196509788","repostType":2,"repost":{"id":"1196509788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629899168,"share":"https://www.laohunote.com/m/news/1196509788?lang=zh_CN&edition=full","pubTime":"2021-08-25 21:46","market":"us","language":"en","title":"Some meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196509788","media":"Tiger Newspress","summary":"Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS and Robinhood fe","content":"<p>Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS&nbsp;and&nbsp;Robinhood&nbsp;fell&nbsp;between 1% and 7%&nbsp;while&nbsp;Naked Brand Group&nbsp;surged&nbsp;7.5%.</p><p><blockquote>一些模因股票在早盘交易中下滑.GameStop、AMC Entertainment、Express、KOSS 和 Robinhood 下跌 1% 至 7%，而 Naked Brand Group 则飙升 7.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3cd4a1e47831725ac5c3611834284345\" tg-width=\"356\" tg-height=\"723\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.</p><p><blockquote>游戏驿站股价在周二上涨 28% 后下滑。但模因股票交易的复苏对于小盘股来说可能是个好消息。</blockquote></p><p> It’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.</p><p><blockquote>与周二的飙升相比，这算不上什么，但对于备忘录股票来说，谁也说不准。</blockquote></p><p> GameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.</p><p><blockquote>自 6 月初见顶以来，游戏驿站股价已下跌近 50%，但一天之内抹去了 40% 的跌幅。它看起来也已经清除了 200 美元左右的阻力，这意味着未来可能还有更多上涨空间。如果 200 美元成为支撑位，请不要感到惊讶。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ca853dd891fce6c2ec9d0ecf67497eb\" tg-width=\"952\" tg-height=\"627\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC)&nbsp;gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.</p><p><blockquote>AMC Entertainment (AMC) 上涨了 20%，与游戏驿站一样，它似乎也清除了阻力，尽管没有那么干净。</blockquote></p><p> For those wondering why we care about these stocks, consider this: AMC is the largest position in the&nbsp;iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have&nbsp;gone nowhere since February.</p><p><blockquote>如果你想知道我们为什么关心这些股票，请考虑一下： AMC 是 iShares Russell 2000 ETF（IWM）中最大的仓位，即使这意味着它只占该指数的 0.5%。如果模因股票继续上涨，这对小盘股来说可能是个好消息，自二月份以来，小盘股一事无成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d97157fe74c2c1baef4735a0dbbc9d67\" tg-width=\"960\" tg-height=\"639\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> “Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”</p><p><blockquote>“Bay Crest Partners 的乔纳森-克林斯基（Jonathan Krinsky）写道：”反弹不错.但还有很多事情需要证明。“IWM 收盘价高于 225 美元将向小盘股发出强烈的看涨信息，并表明目前为期七个月的盘整实际上正在走高。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-25 21:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS&nbsp;and&nbsp;Robinhood&nbsp;fell&nbsp;between 1% and 7%&nbsp;while&nbsp;Naked Brand Group&nbsp;surged&nbsp;7.5%.</p><p><blockquote>一些模因股票在早盘交易中下滑.GameStop、AMC Entertainment、Express、KOSS 和 Robinhood 下跌 1% 至 7%，而 Naked Brand Group 则飙升 7.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3cd4a1e47831725ac5c3611834284345\" tg-width=\"356\" tg-height=\"723\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.</p><p><blockquote>游戏驿站股价在周二上涨 28% 后下滑。但模因股票交易的复苏对于小盘股来说可能是个好消息。</blockquote></p><p> It’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.</p><p><blockquote>与周二的飙升相比，这算不上什么，但对于备忘录股票来说，谁也说不准。</blockquote></p><p> GameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.</p><p><blockquote>自 6 月初见顶以来，游戏驿站股价已下跌近 50%，但一天之内抹去了 40% 的跌幅。它看起来也已经清除了 200 美元左右的阻力，这意味着未来可能还有更多上涨空间。如果 200 美元成为支撑位，请不要感到惊讶。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ca853dd891fce6c2ec9d0ecf67497eb\" tg-width=\"952\" tg-height=\"627\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC)&nbsp;gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.</p><p><blockquote>AMC Entertainment (AMC) 上涨了 20%，与游戏驿站一样，它似乎也清除了阻力，尽管没有那么干净。</blockquote></p><p> For those wondering why we care about these stocks, consider this: AMC is the largest position in the&nbsp;iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have&nbsp;gone nowhere since February.</p><p><blockquote>如果你想知道我们为什么关心这些股票，请考虑一下： AMC 是 iShares Russell 2000 ETF（IWM）中最大的仓位，即使这意味着它只占该指数的 0.5%。如果模因股票继续上涨，这对小盘股来说可能是个好消息，自二月份以来，小盘股一事无成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d97157fe74c2c1baef4735a0dbbc9d67\" tg-width=\"960\" tg-height=\"639\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> “Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”</p><p><blockquote>“Bay Crest Partners 的乔纳森-克林斯基（Jonathan Krinsky）写道：”反弹不错.但还有很多事情需要证明。“IWM 收盘价高于 225 美元将向小盘股发出强烈的看涨信息，并表明目前为期七个月的盘整实际上正在走高。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KOSS":"高斯电子","AMC":"AMC院线","GME":"游戏驿站","EXPR":"Express, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196509788","content_text":"Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS and Robinhood fell between 1% and 7% while Naked Brand Group surged 7.5%.\n\nGameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.\nIt’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.\nGameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.\n\nGameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC) gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.\nFor those wondering why we care about these stocks, consider this: AMC is the largest position in the iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have gone nowhere since February.\n\n“Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”","news_type":1,"symbols_score_info":{"KOSS":0.9,"GME":0.9,"NAKD":0.9,"AMC":0.9,"EXPR":0.9}},"isVote":1,"tweetType":1,"viewCount":2605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803980571,"gmtCreate":1627400893493,"gmtModify":1633765337915,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577793809591330","authorIdStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Buy the dip on NIO?","listText":"Buy the dip on NIO?","text":"Buy the dip on NIO?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/803980571","repostId":"1191522112","repostType":2,"repost":{"id":"1191522112","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627399476,"share":"https://www.laohunote.com/m/news/1191522112?lang=zh_CN&edition=full","pubTime":"2021-07-27 23:24","market":"us","language":"zh","title":"中概股跌幅持续扩大，小鹏汽车跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191522112","media":"老虎资讯综合","summary":"7月27日，中概股跌幅持续扩大，小鹏汽车跌超15%，理想汽车跌超11%，拼多多跌超10%，蔚来、哔哩哔哩跌超9%，阿里巴巴、京东、百度跌超5%.","content":"<p>7月27日，中概股跌幅持续扩大，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌超15%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌超11%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌超10%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超9%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌超5%.</p>\n<p><img src=\"https://static.tigerbbs.com/fa78e3c7e10ba06edbd438da6686c91d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中概股跌幅持续扩大，小鹏汽车跌超15%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中概股跌幅持续扩大，小鹏汽车跌超15%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-27 23:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月27日，中概股跌幅持续扩大，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌超15%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌超11%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌超10%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超9%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌超5%.</p>\n<p><img src=\"https://static.tigerbbs.com/fa78e3c7e10ba06edbd438da6686c91d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","relate_stocks":{"PDD":"拼多多","TTTN":"老虎中美互联网巨头ETF","QNETCN":"纳斯达克中美互联网老虎指数","09868":"小鹏集团-W","NIO":"蔚来","LI":"理想汽车","BIDU":"百度","JD":"京东","BABA":"阿里巴巴","BILI":"哔哩哔哩","XPEV":"小鹏集团"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191522112","content_text":"7月27日，中概股跌幅持续扩大，小鹏汽车跌超15%，理想汽车跌超11%，拼多多跌超10%，蔚来、哔哩哔哩跌超9%，阿里巴巴、京东、百度跌超5%.","news_type":1,"symbols_score_info":{"TTTN":0.9,"QNETCN":0.9,"PDD":0.9,"NIO":0.9,"XPEV":0.9,"BABA":0.9,"BILI":0.9,"09868":0.9,"LI":0.9,"BIDU":0.9,"JD":0.9}},"isVote":1,"tweetType":1,"viewCount":2225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":609888045,"gmtCreate":1638264393592,"gmtModify":1638264456117,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577793809591330","idStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Didn't he say earlier it's good to go for 2022???","listText":"Didn't he say earlier it's good to go for 2022???","text":"Didn't he say earlier it's good to go for 2022???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609888045","repostId":"1176161322","repostType":2,"repost":{"id":"1176161322","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638263039,"share":"https://www.laohunote.com/m/news/1176161322?lang=zh_CN&edition=full","pubTime":"2021-11-30 17:03","market":"us","language":"en","title":"Moderna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176161322","media":"Tiger Newspress","summary":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective agai","content":"<p>Moderna stock slid 1.5% in premarket trading&nbsp;as&nbsp;Moderna CEO said vaccines likely less effective against Omicron.</p><p><blockquote>Moderna 首席执行官表示疫苗对奥密克戎的效果可能较差，Moderna 股价在盘前交易中下跌 1.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>制药商 Moderna 的负责人表示，新冠肺炎疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对疫情轨迹的新担忧。</blockquote></p><p> \"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 在接受英国《金融时报》采访时表示：“我认为，没有哪个世界（效率）能达到与达美航空相同的水平……”</blockquote></p><p> \"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p><p><blockquote>“我认为这将是一个物质下降。我只是不知道下降多少，因为我们需要等待数据。但我交谈过的所有科学家......都说‘这不会是好的’。”</blockquote></p><p> Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p><p><blockquote>疫苗耐药性可能会导致更多的疾病和住院，并延长疫情，他的言论引发了石油、股票和澳元等增长风险资产的抛售。</blockquote></p><p> Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p><p><blockquote>班塞尔补充说，病毒用来感染人类细胞的蛋白质刺突有大量突变，这意味着目前的疫苗作物可能需要修改。</blockquote></p><p> He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p><p><blockquote>他早些时候在 CNBC 上表示，可能需要几个月的时间才能开始运送一种确实有效对抗奥密克戎的疫苗。</blockquote></p><p> Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p><p><blockquote>尽管缺乏关于其严重性的信息，但对新变种的恐惧已经引发了一些经济重新开放计划的延迟，以及一些旅行和行动限制的重新实施。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock slid 1.5% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌 1.5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-30 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna stock slid 1.5% in premarket trading&nbsp;as&nbsp;Moderna CEO said vaccines likely less effective against Omicron.</p><p><blockquote>Moderna 首席执行官表示疫苗对奥密克戎的效果可能较差，Moderna 股价在盘前交易中下跌 1.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/dba337733c64956ca75b06171ffc5745\" tg-width=\"851\" tg-height=\"621\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>制药商 Moderna 的负责人表示，新冠肺炎疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对疫情轨迹的新担忧。</blockquote></p><p> \"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 在接受英国《金融时报》采访时表示：“我认为，没有哪个世界（效率）能达到与达美航空相同的水平……”</blockquote></p><p> \"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p><p><blockquote>“我认为这将是一个物质下降。我只是不知道下降多少，因为我们需要等待数据。但我交谈过的所有科学家......都说‘这不会是好的’。”</blockquote></p><p> Vaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.</p><p><blockquote>疫苗耐药性可能会导致更多的疾病和住院，并延长疫情，他的言论引发了石油、股票和澳元等增长风险资产的抛售。</blockquote></p><p> Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.</p><p><blockquote>班塞尔补充说，病毒用来感染人类细胞的蛋白质刺突有大量突变，这意味着目前的疫苗作物可能需要修改。</blockquote></p><p> He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.</p><p><blockquote>他早些时候在 CNBC 上表示，可能需要几个月的时间才能开始运送一种确实有效对抗奥密克戎的疫苗。</blockquote></p><p> Fear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.</p><p><blockquote>尽管缺乏关于其严重性的信息，但对新变种的恐惧已经引发了一些经济重新开放计划的延迟，以及一些旅行和行动限制的重新实施。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176161322","content_text":"Moderna stock slid 1.5% in premarket trading as Moderna CEO said vaccines likely less effective against Omicron.\n\nThe head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nVaccine resistance could lead to more sickness and hospitalisations and prolong the pandemic, and his comments triggered selling in growth-exposed assets like oil, stocks and the Australian dollar.\nBancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified.\nHe had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron.\nFear of the new variant, despite a lack of information about its severity, has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3895,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837488653,"gmtCreate":1629905341372,"gmtModify":1633681558541,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577793809591330","idStr":"3577793809591330"},"themes":[],"title":"","htmlText":"lets get some volume in.","listText":"lets get some volume in.","text":"lets get some volume in.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837488653","repostId":"1196509788","repostType":2,"repost":{"id":"1196509788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629899168,"share":"https://www.laohunote.com/m/news/1196509788?lang=zh_CN&edition=full","pubTime":"2021-08-25 21:46","market":"us","language":"en","title":"Some meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196509788","media":"Tiger Newspress","summary":"Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS and Robinhood fe","content":"<p>Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS&nbsp;and&nbsp;Robinhood&nbsp;fell&nbsp;between 1% and 7%&nbsp;while&nbsp;Naked Brand Group&nbsp;surged&nbsp;7.5%.</p><p><blockquote>一些模因股票在早盘交易中下滑.GameStop、AMC Entertainment、Express、KOSS 和 Robinhood 下跌 1% 至 7%，而 Naked Brand Group 则飙升 7.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3cd4a1e47831725ac5c3611834284345\" tg-width=\"356\" tg-height=\"723\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.</p><p><blockquote>游戏驿站股价在周二上涨 28% 后下滑。但模因股票交易的复苏对于小盘股来说可能是个好消息。</blockquote></p><p> It’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.</p><p><blockquote>与周二的飙升相比，这算不上什么，但对于备忘录股票来说，谁也说不准。</blockquote></p><p> GameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.</p><p><blockquote>自 6 月初见顶以来，游戏驿站股价已下跌近 50%，但一天之内抹去了 40% 的跌幅。它看起来也已经清除了 200 美元左右的阻力，这意味着未来可能还有更多上涨空间。如果 200 美元成为支撑位，请不要感到惊讶。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ca853dd891fce6c2ec9d0ecf67497eb\" tg-width=\"952\" tg-height=\"627\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC)&nbsp;gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.</p><p><blockquote>AMC Entertainment (AMC) 上涨了 20%，与游戏驿站一样，它似乎也清除了阻力，尽管没有那么干净。</blockquote></p><p> For those wondering why we care about these stocks, consider this: AMC is the largest position in the&nbsp;iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have&nbsp;gone nowhere since February.</p><p><blockquote>如果你想知道我们为什么关心这些股票，请考虑一下： AMC 是 iShares Russell 2000 ETF（IWM）中最大的仓位，即使这意味着它只占该指数的 0.5%。如果模因股票继续上涨，这对小盘股来说可能是个好消息，自二月份以来，小盘股一事无成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d97157fe74c2c1baef4735a0dbbc9d67\" tg-width=\"960\" tg-height=\"639\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> “Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”</p><p><blockquote>“Bay Crest Partners 的乔纳森-克林斯基（Jonathan Krinsky）写道：”反弹不错.但还有很多事情需要证明。“IWM 收盘价高于 225 美元将向小盘股发出强烈的看涨信息，并表明目前为期七个月的盘整实际上正在走高。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome meme stocks slipped in morning trading<blockquote>一些模因股票在早盘交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-25 21:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS&nbsp;and&nbsp;Robinhood&nbsp;fell&nbsp;between 1% and 7%&nbsp;while&nbsp;Naked Brand Group&nbsp;surged&nbsp;7.5%.</p><p><blockquote>一些模因股票在早盘交易中下滑.GameStop、AMC Entertainment、Express、KOSS 和 Robinhood 下跌 1% 至 7%，而 Naked Brand Group 则飙升 7.5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3cd4a1e47831725ac5c3611834284345\" tg-width=\"356\" tg-height=\"723\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.</p><p><blockquote>游戏驿站股价在周二上涨 28% 后下滑。但模因股票交易的复苏对于小盘股来说可能是个好消息。</blockquote></p><p> It’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.</p><p><blockquote>与周二的飙升相比，这算不上什么，但对于备忘录股票来说，谁也说不准。</blockquote></p><p> GameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.</p><p><blockquote>自 6 月初见顶以来，游戏驿站股价已下跌近 50%，但一天之内抹去了 40% 的跌幅。它看起来也已经清除了 200 美元左右的阻力，这意味着未来可能还有更多上涨空间。如果 200 美元成为支撑位，请不要感到惊讶。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ca853dd891fce6c2ec9d0ecf67497eb\" tg-width=\"952\" tg-height=\"627\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> GameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC)&nbsp;gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.</p><p><blockquote>AMC Entertainment (AMC) 上涨了 20%，与游戏驿站一样，它似乎也清除了阻力，尽管没有那么干净。</blockquote></p><p> For those wondering why we care about these stocks, consider this: AMC is the largest position in the&nbsp;iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have&nbsp;gone nowhere since February.</p><p><blockquote>如果你想知道我们为什么关心这些股票，请考虑一下： AMC 是 iShares Russell 2000 ETF（IWM）中最大的仓位，即使这意味着它只占该指数的 0.5%。如果模因股票继续上涨，这对小盘股来说可能是个好消息，自二月份以来，小盘股一事无成。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d97157fe74c2c1baef4735a0dbbc9d67\" tg-width=\"960\" tg-height=\"639\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> “Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”</p><p><blockquote>“Bay Crest Partners 的乔纳森-克林斯基（Jonathan Krinsky）写道：”反弹不错.但还有很多事情需要证明。“IWM 收盘价高于 225 美元将向小盘股发出强烈的看涨信息，并表明目前为期七个月的盘整实际上正在走高。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KOSS":"高斯电子","AMC":"AMC院线","GME":"游戏驿站","EXPR":"Express, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196509788","content_text":"Some meme stocks slipped in morning trading.GameStop,AMC Entertainment,Express,KOSS and Robinhood fell between 1% and 7% while Naked Brand Group surged 7.5%.\n\nGameStop stock was slipping after gaining 28% on Tuesday. But the revival of the meme-stock trade could be good news for small-cap stocks generally.\nIt’s not much of a move compared with Tuesday’s surge, but with meme stocks, one never can tell.\nGameStop stock had dropped nearly 50% since peaking in early June, but erased 40% of that drop in one day. It also looks to have cleared resistance at about $200, which means there could be more upside ahead. Don’t be surprised if $200 becomes support.\n\nGameStop wasn’t the only meme stock on the move Tuesday.AMC Entertainment(AMC) gained 20%, and like GameStop, it appeared to clear resistance, though not quite as cleanly.\nFor those wondering why we care about these stocks, consider this: AMC is the largest position in the iShares Russell 2000 ETF(IWM), even if that means it’s just 0.5% of the index. If the meme stocks keep rising that could be good news for small-caps, which have gone nowhere since February.\n\n“Nice bounce …but a lot still to prove,” writes Bay Crest Partners’ Jonathan Krinsky. “IWM closing above $225 would send a strong bullish message for small-caps, and suggest the now seven-month consolidation is, in fact, resolving higher.”","news_type":1,"symbols_score_info":{"KOSS":0.9,"GME":0.9,"NAKD":0.9,"AMC":0.9,"EXPR":0.9}},"isVote":1,"tweetType":1,"viewCount":2605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":603468710,"gmtCreate":1638440850258,"gmtModify":1638440971157,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577793809591330","idStr":"3577793809591330"},"themes":[],"title":"","htmlText":"It's dropping like no tmw... hold?","listText":"It's dropping like no tmw... hold?","text":"It's dropping like no tmw... hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603468710","repostId":"1138497635","repostType":2,"repost":{"id":"1138497635","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638436217,"share":"https://www.laohunote.com/m/news/1138497635?lang=zh_CN&edition=full","pubTime":"2021-12-02 17:10","market":"us","language":"en","title":"Moderna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138497635","media":"Tiger Newspress","summary":"Moderna shares dipped more than 2% in premarket trading as it could be sued over vaccines as court u","content":"<p>Moderna shares dipped more than&nbsp;2% in premarket trading&nbsp;as&nbsp;it&nbsp;could be sued over vaccines as court upholds Arbutus patents.</p><p><blockquote>由于法院支持杨梅专利，Moderna 股价在盘前交易中下跌超过 2%，该公司可能因疫苗被起诉。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c4b23d228b24ede7e56c373ea5ecd787\" tg-width=\"853\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Moderna Inc&nbsp;could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.</p><p><blockquote>在联邦上诉法院周三驳回了 Moderna Inc 对 Arbutus Biopharma Corp. 专利的质疑后，Moderna Inc 可能面临其 COVID-19 疫苗的专利侵权诉讼。</blockquote></p><p> The Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.</p><p><blockquote>美国联邦巡回上诉法院维持了行政小组的调查结果，即杨梅的专利（可能涵盖疫苗中使用的技术）是有效的，因为所涉及的科学以前并不为人所知。</blockquote></p><p> Moderna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.</p><p><blockquote>Moderna 此前在法庭文件中表示，如果专利得到支持，它认为 Arbutus 可能会提起诉讼，要求其 COVID-19 疫苗支付版税。</blockquote></p><p> The company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.</p><p><blockquote>该公司上个月预测，其 COVID-19 疫苗 2021 年销售额将在 150 亿至 180 亿美元之间，2022 年销售额将在 170 亿至 220 亿美元之间。</blockquote></p><p> Jefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.</p><p><blockquote>Jefferies 分析师 Dennis Ding 表示，侵权诉讼是可能的，但可能会拖延数年，并补充说 Arbutus 可能会满足于少量版税。</blockquote></p><p> \"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.</p><p><blockquote>“当你考虑疫苗带来的收入机会时，就像每年 10 亿美元到 200 亿美元一样，少量的低个位数特许权使用费对 Moderna 来说并不重要，”他说。</blockquote></p><p> Both patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.</p><p><blockquote>这两项专利都涉及所谓的脂质纳米颗粒，这些纳米颗粒将遗传物质（称为信使 RNA (mRNA)）包裹在疫苗中。这项技术可能有助于开发未来针对其他疾病的基于mRNA的疫苗。</blockquote></p><p> Moderna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.</p><p><blockquote>Moderna 最初向联邦专利局下属的美国专利审判和上诉委员会对这些专利提出质疑。委员会同意Moderna的观点，即其中一项专利的某些部分无效，但在其他方面支持Arbutus，联邦巡回法院维持了其调查结果。</blockquote></p><p> The patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.</p><p><blockquote>这些专利授权给 Genevant Sciences Inc.，该公司由 Arbutus 和 Roivant Sciences Ltd. 于 2018 年创立。Roivant 拥有 Genevant 约 80% 的股份，Arbutus 拥有其余部分。</blockquote></p><p> Moderna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).</p><p><blockquote>Moderna 还卷入了与美国国立卫生研究院 (NIH) 长达数月的 COVID-19 疫苗专利冲突。</blockquote></p><p> NIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.</p><p><blockquote>NIH 声称，其三名科学家帮助设计了 Moderna 价值数十亿美元的疫苗中使用的基因序列，并应在专利申请中命名，但该公司不同意这一说法。</blockquote></p><p> The company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.</p><p><blockquote>该公司坚称，该公司疫苗中的mRNA序列是由Moderna的科学家独家选择的，没有NIH科学家的输入。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna shares dipped more than 2% in premarket trading<blockquote>Moderna 股价在盘前交易中下跌超过 2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-02 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna shares dipped more than&nbsp;2% in premarket trading&nbsp;as&nbsp;it&nbsp;could be sued over vaccines as court upholds Arbutus patents.</p><p><blockquote>由于法院支持杨梅专利，Moderna 股价在盘前交易中下跌超过 2%，该公司可能因疫苗被起诉。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c4b23d228b24ede7e56c373ea5ecd787\" tg-width=\"853\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Moderna Inc&nbsp;could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.</p><p><blockquote>在联邦上诉法院周三驳回了 Moderna Inc 对 Arbutus Biopharma Corp. 专利的质疑后，Moderna Inc 可能面临其 COVID-19 疫苗的专利侵权诉讼。</blockquote></p><p> The Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.</p><p><blockquote>美国联邦巡回上诉法院维持了行政小组的调查结果，即杨梅的专利（可能涵盖疫苗中使用的技术）是有效的，因为所涉及的科学以前并不为人所知。</blockquote></p><p> Moderna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.</p><p><blockquote>Moderna 此前在法庭文件中表示，如果专利得到支持，它认为 Arbutus 可能会提起诉讼，要求其 COVID-19 疫苗支付版税。</blockquote></p><p> The company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.</p><p><blockquote>该公司上个月预测，其 COVID-19 疫苗 2021 年销售额将在 150 亿至 180 亿美元之间，2022 年销售额将在 170 亿至 220 亿美元之间。</blockquote></p><p> Jefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.</p><p><blockquote>Jefferies 分析师 Dennis Ding 表示，侵权诉讼是可能的，但可能会拖延数年，并补充说 Arbutus 可能会满足于少量版税。</blockquote></p><p> \"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.</p><p><blockquote>“当你考虑疫苗带来的收入机会时，就像每年 10 亿美元到 200 亿美元一样，少量的低个位数特许权使用费对 Moderna 来说并不重要，”他说。</blockquote></p><p> Both patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.</p><p><blockquote>这两项专利都涉及所谓的脂质纳米颗粒，这些纳米颗粒将遗传物质（称为信使 RNA (mRNA)）包裹在疫苗中。这项技术可能有助于开发未来针对其他疾病的基于mRNA的疫苗。</blockquote></p><p> Moderna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.</p><p><blockquote>Moderna 最初向联邦专利局下属的美国专利审判和上诉委员会对这些专利提出质疑。委员会同意Moderna的观点，即其中一项专利的某些部分无效，但在其他方面支持Arbutus，联邦巡回法院维持了其调查结果。</blockquote></p><p> The patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.</p><p><blockquote>这些专利授权给 Genevant Sciences Inc.，该公司由 Arbutus 和 Roivant Sciences Ltd. 于 2018 年创立。Roivant 拥有 Genevant 约 80% 的股份，Arbutus 拥有其余部分。</blockquote></p><p> Moderna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).</p><p><blockquote>Moderna 还卷入了与美国国立卫生研究院 (NIH) 长达数月的 COVID-19 疫苗专利冲突。</blockquote></p><p> NIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.</p><p><blockquote>NIH 声称，其三名科学家帮助设计了 Moderna 价值数十亿美元的疫苗中使用的基因序列，并应在专利申请中命名，但该公司不同意这一说法。</blockquote></p><p> The company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.</p><p><blockquote>该公司坚称，该公司疫苗中的mRNA序列是由Moderna的科学家独家选择的，没有NIH科学家的输入。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138497635","content_text":"Moderna shares dipped more than 2% in premarket trading as it could be sued over vaccines as court upholds Arbutus patents.\n\nModerna Inc could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to Arbutus Biopharma Corp.\nThe Federal Circuit U.S. Court of Appeals let stand an administrative panel's findings that Arbutus' patents - which may cover technology used in the vaccines - are valid, as the science involved was not previously known.\nModerna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents were upheld.\nThe company last month forecast 2021 sales of between $15 billion and $18 billion, and 2022 sales of between $17 billion and $22 billion, for its COVID-19 vaccine.\nJefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty.\n\"When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna,\" he said.\nBoth patents in question involve the so-called lipid nanoparticles that enclose the genetic material, known as messenger RNA (mRNA), in the vaccine. The technology could prove useful in developing future mRNA-based vaccines against other illnesses as well.\nModerna initially challenged the patents before the U.S. Patent Trial and Appeal Board, part of the federal patent office. The board agreed with Moderna that some portions of one of the patents were invalid but otherwise sided with Arbutus, and the Federal Circuit upheld its findings.\nThe patents are licensed to Genevant Sciences Inc, a company launched in 2018 by Arbutus and Roivant Sciences Ltd. Roivant owns about 80% of Genevant and Arbutus owns the remainder.\nModerna is also embroiled in a months-long patent conflict over its COVID-19 vaccine with the U.S. National Institutes of Health (NIH).\nNIH has asserted that three of its scientists helped design the genetic sequence used in Moderna's multibillion-dollar vaccine and should be named on the patent application, a claim the company disagrees with.\nThe company maintains that the mRNA sequence in the company's vaccine was selected exclusively by Moderna's scientists, and without input of NIH scientists.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":4328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601845900,"gmtCreate":1638514700795,"gmtModify":1638514700890,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577793809591330","idStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Finally?!!","listText":"Finally?!!","text":"Finally?!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601845900","repostId":"1149654291","repostType":2,"repost":{"id":"1149654291","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638514400,"share":"https://www.laohunote.com/m/news/1149654291?lang=zh_CN&edition=full","pubTime":"2021-12-03 14:53","market":"us","language":"en","title":"Didi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1149654291","media":"Tiger Newspress","summary":"It's reported that Didi reintroduces its apps in Apple Store.\nHowever, Didi said that it was a rumor","content":"<p>It's&nbsp;reported&nbsp;that&nbsp;Didi&nbsp;reintroduces its apps in Apple&nbsp;Store.</p><p><blockquote>据悉，滴滴将在苹果商店重新推出其应用程序。</blockquote></p><p> However,&nbsp;Didi&nbsp;said&nbsp;that&nbsp;it&nbsp;was&nbsp;a&nbsp;rumor.</p><p><blockquote>不过，滴滴方面表示，这是谣言。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Didi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDidi reintroduces its apps in Apple Store.<blockquote>滴滴在苹果商店重新推出其应用程序。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 14:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>It's&nbsp;reported&nbsp;that&nbsp;Didi&nbsp;reintroduces its apps in Apple&nbsp;Store.</p><p><blockquote>据悉，滴滴将在苹果商店重新推出其应用程序。</blockquote></p><p> However,&nbsp;Didi&nbsp;said&nbsp;that&nbsp;it&nbsp;was&nbsp;a&nbsp;rumor.</p><p><blockquote>不过，滴滴方面表示，这是谣言。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149654291","content_text":"It's reported that Didi reintroduces its apps in Apple Store.\nHowever, Didi said that it was a rumor.","news_type":1,"symbols_score_info":{"DIDI":0.9}},"isVote":1,"tweetType":1,"viewCount":2742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":803980571,"gmtCreate":1627400893493,"gmtModify":1633765337915,"author":{"id":"3577793809591330","authorId":"3577793809591330","name":"SquatMachine","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577793809591330","idStr":"3577793809591330"},"themes":[],"title":"","htmlText":"Buy the dip on NIO?","listText":"Buy the dip on NIO?","text":"Buy the dip on NIO?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/803980571","repostId":"1191522112","repostType":2,"repost":{"id":"1191522112","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627399476,"share":"https://www.laohunote.com/m/news/1191522112?lang=zh_CN&edition=full","pubTime":"2021-07-27 23:24","market":"us","language":"zh","title":"中概股跌幅持续扩大，小鹏汽车跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191522112","media":"老虎资讯综合","summary":"7月27日，中概股跌幅持续扩大，小鹏汽车跌超15%，理想汽车跌超11%，拼多多跌超10%，蔚来、哔哩哔哩跌超9%，阿里巴巴、京东、百度跌超5%.","content":"<p>7月27日，中概股跌幅持续扩大，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌超15%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌超11%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌超10%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超9%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌超5%.</p>\n<p><img src=\"https://static.tigerbbs.com/fa78e3c7e10ba06edbd438da6686c91d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中概股跌幅持续扩大，小鹏汽车跌超15%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中概股跌幅持续扩大，小鹏汽车跌超15%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-27 23:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月27日，中概股跌幅持续扩大，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌超15%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌超11%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌超10%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌超9%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌超5%.</p>\n<p><img src=\"https://static.tigerbbs.com/fa78e3c7e10ba06edbd438da6686c91d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","relate_stocks":{"PDD":"拼多多","TTTN":"老虎中美互联网巨头ETF","QNETCN":"纳斯达克中美互联网老虎指数","09868":"小鹏集团-W","NIO":"蔚来","LI":"理想汽车","BIDU":"百度","JD":"京东","BABA":"阿里巴巴","BILI":"哔哩哔哩","XPEV":"小鹏集团"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191522112","content_text":"7月27日，中概股跌幅持续扩大，小鹏汽车跌超15%，理想汽车跌超11%，拼多多跌超10%，蔚来、哔哩哔哩跌超9%，阿里巴巴、京东、百度跌超5%.","news_type":1,"symbols_score_info":{"TTTN":0.9,"QNETCN":0.9,"PDD":0.9,"NIO":0.9,"XPEV":0.9,"BABA":0.9,"BILI":0.9,"09868":0.9,"LI":0.9,"BIDU":0.9,"JD":0.9}},"isVote":1,"tweetType":1,"viewCount":2225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}